Caffeine and cognitive decline in elderly women at high vascular risk

Journal of Alzheimer's Disease

Volumn 35, Issue 2, 2013, Pages 413-421

  Vercambre, Marie Noël ^a   Berr, Claudine ^b,c   Ritchie, Karen ^b,c   Kang, Jae H ^d  

^a MGEN Foundation for Public Health   (France)

^b INSERM U1061   (France)

^c UNIV MONTPELLIER   (France)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aging; caffeine; cognition; cohort studies; epidemiology; risk factors

Indexed keywords

ANTIOXIDANT; CAFFEINE; VITAMIN B GROUP;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENTAL DETERIORATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SPEECH; TELECONSULTATION; VERBAL MEMORY; VISUAL MEMORY; VITAMIN SUPPLEMENTATION;

EID: 84877154857     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122371     Document Type: Article

References (43)

1. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51, 83-133
2. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R (2012) Association of coffee drinking with total and causespecific mortality. N Engl J Med 366, 1891-1904
3. Ritchie K, Carriere I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 69, 536-545
4. van Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study. Eur J Clin Nutr 61, 226-232
5. Santos C, Lunet N, Azevedo A, De Mendonça A, Ritchie K, Barros H (2010) Caffeine intake is associated with a lower risk of cognitive decline: A cohort study from Portugal. J Alzheimers Dis 20, 175-185
6. Arab L, Biggs ML, O'Meara ES, Longstreth WT, Crane PK, Fitzpatrick AL (2011) Gender differences in tea, coffee, and cognitive decline in the elderly: The cardiovascular health study. J Alzheimers Dis 27, 553-566
7. 2012) A united approach to vascular disease and neurodegeneration. Lancet Neurol 11, 293
8. Frary CD, Johnson RK, Wang MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105, 110-113
9. Garriguet D (2008) Beverage consumption of Canadian adults. Health Rep 19, 23-29
10. Pase MP, Grima NA, Stough CK, Scholey A, Pipingas A (2012) Cardiovascular disease risk and cerebral blood flow velocity. Stroke 43, 2803-2805
11. van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA 294, 97-104
12. Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ,Wang CL, Chen YM (2009) Coffee consumption and risk of coronary heart diseases: A meta-Analysis of 21 prospective cohort studies. Int J Cardiol 137, 216-225
13. Mostofsky E, Rice MS, Levitan EB, Mittleman MA (2012) Habitual coffee consumption and risk of heart failure:Adoseresponse meta-Analysis. Circ Heart Fail 5, 401-405
14. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Mukamal KJ, Hu FB, van Dam RM (2011) Coffee consumption and mortality in women with cardiovasculardisease. Am J Clin Nutr 94, 218-224
15. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE (2007) A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from theWomen's Antioxidant Cardiovascular Study. Arch Intern Med 167, 1610-1618
16. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 299, 2027-2036
17. Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F (2008) A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 88, 1602-1610
18. Kang JH, Cook NR, Manson JE, Buring JE, Albert CM, Grodstein F (2009) Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation 119, 2772-2780
19. Vercambre MN, Grodstein F, Berr C, Kang JH (2012) Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors. J Acad Nutr Diet 112, 816-823
20. Vercambre MN, Grodstein F, Manson JE, Stampfer MJ, Kang JH (2011) Physical activity and cognition in women with vascular conditions. Arch Intern Med 171, 1244-1250
21. Brandt J, Spencer M, Folstein M (1988) The telephone Interview for Cognitive Status. Neuropsych Neuropsychol Behav Neurol 1, 111-117
22. Scherr PA, Albert MS, Funkenstein HH, Cook NR, Hennekens CH, Branch LG, White LR, Taylor JO, Evans DA (1988) Correlates of cognitive function in an elderly community population. Am J Epidemiol 128, 1084-1101
23. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39, 1159-1165
24. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L (2000) The course of cognitive impairment in preclinical Alzheimer disease: Three-And 6-year follow-up of a population-based sample. Arch Neurol 57, 839-844
25. Robinson G, Shallice T, Bozzali M, Cipolotti L (2012) The differing roles of the frontal cortex in fluency tests. Brain 135, 2202-2214
26. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M(2005) The pattern of cognitive performance in CADASIL: A monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry 162, 2078-2085
27. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122, 51-65
28. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC (1989) Food-based validation of a dietary questionnaire: The effects of week-To-week variation in food consumption. Int J Epidemiol 18, 858-867
29. Willett W, Stampfer MJ (1986) Total energy intake: Implications for epidemiologic analyses.AmJ Epidemiol 124, 17-27
30. Santos C, Costa Jo, Santos Jo, Vaz-Carneiro An, Lunet N (2010) Caffeine intake and dementia: Systematic review and meta-Analysis. J Alzheimers Dis 20, 187-204
31. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin M-L, Carriere I (2010) Caffeine, cognitive functioning, and white matter lesions in the elderly: Establishing causality from epidemiological evidence. J Alzheimers Dis 20, 161-166
32. Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR (2011) Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 23, 607-615
33. Dall'Igna OP, Fett P, GomesMW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A (2a) receptor antagonists prevent beta-Amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203, 241-245
34. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-Amyloid production. Neuroscience 142, 941-952
35. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, ArendashGW, Holtzman DM, Potter H (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 17, 681-697
36. ArendashGW, MoriT, Cao C, MamcarzM,RunfeldtM,Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17, 661-680
37. Duarte JMN, Agostinho PM, Carvalho RA, Cunha RA (2012) Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/ LTJ mice. PLoS ONE 7, e21899
38. Lucas M, Mirzaei F, PanA,Okereke OI,Willett WC, O'Reilly EJ, Koenen K, Ascherio A (2011) Coffee, caffeine, and risk of depression among women. Arch Intern Med 171, 1571-1578.
39. Beaudreau SA, O'Hara R (2009) The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. Psychol Aging 24, 507-512.
40. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB (2002) Contribution of caffeine to the homocysteine-raising effect of coffee: A randomized controlled trial in humans. Am J Clin Nutr 76, 1244-1248.
41. Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580, 2994-3005.
42. MacGregor JT, Schlegel R, Wehr CM, Alperin P, Ames BN (1990) Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. Proc Natl Acad Sci 87, 9962-9965.
43. Shukitt-Hale B, Miller MG, Chu YF, Lyle BJ, Joseph JA. (2013) Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging. Age (Dordr), in press, doi: 10.1007/s11357-012-9509-4.